ADM’s global VP of R&D in Health and Wellness, Dr. Peter Jüsten, tells us that the gastrointestinal microbiome is a new frontier in animal health and wellness. He highlights how the company’s recently opened R&D center in Switzerland integrates new technologies, specifically in pre-clinical in vitro models, to speed up product development and research. Jüsten adds that the center aims to develop solutions that support animal performance and the ability to reach their full genetic potential, enhance animal robustness to quickly recover from disease challenges or changing conditions, and mitigate the environmental impact of animal production.
Upcoming webinars

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients















